A THERAPEUTIC COMBINATION, USEFUL FOR THE TREATMENT OR PREVENTION OF BENIGN PROSTATIC HYPERPLASIA, IS INCLUDED, INCLUDING AN ANTIESTROGEN OR AT LEAST AN ADDITIONAL ACTIVE INGREDIENT BETWEEN THE GROUP FORMED BY INHIBITORS OF THE ACTIVITY OF THE AIBAT ACTIVITY AL - REDUCTASA. PHARMACEUTICAL COMPOSITIONS AND USEFUL SETS ARE PROVIDED FOR SUCH TREATMENT.
展开▼